| Name | Title | Contact Details |
|---|---|---|
Mark Buttkus |
Chief Technology Officer | Profile |
PhotoMedex is a leader in the dermatology market, committed to the Science of Skin Health in disease management and skin rejuvenation. We focus our efforts where we can make meaningful differences in dermatological applications for psoriasis and vitiligo, therapeutic skin care and LED therapy for acne and photodamage. Our Purpose, to provide branded dermatological solutions of superior value to improve patients` lives now and into the future, is our common goal and leads our thinking. The results of which will be realized in physicians and patients rewarding us with winning sales, profit and equity generation. Our commitment to safety and efficacy is reflected in our dedication to scientific development and has led to a broad range of FDA clearances. XTRAC was the first FDA market-cleared excimer laser system for the treatment of dermatological applications, including psoriasis and vitiligo. The Omnilux LED system carries FDA clearances for skin rejuvenation, acne and pain management. Neova, the science of skin care, holds dozens of patents on its clinically proven Copper Peptide technology for skin health, hair care and wound care.
Physician Health Partners is a Denver, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Newcastle Place is a Mequon, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
We connect world class science to consumer health. We use science and math to enable average consumers to understand their health risk relative to their peers (age & gender) based on their behaviors. We enable organizations to develop affinity with their members, employees, patients and customers by facilitating consumer-driven, personalized user experiences. We do the heavy lifting and provide you with the data. We facilitate a permanent relationship with consumers, providing value as an entry point to preventative self-directed healthcare.
BioQ Pharma is a late stage specialty pharmaceutical company focused on developing and commercializing a portfolio of large volume ready-to-use infusible pharmaceuticals. Our vision is to set a new standard of care in the presentation and administration of infusible pharmaceuticals via our proprietary unit-dose infusion systems that can be deployed quickly and conveniently at the point of care with one touch. Our infusion platform is intended to address some of the most pressing unmet needs in infusion today: cost, medication error, sterility, efficiency, and patient quality of life.